Absher Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,970
Closed -$203K 83
2025
Q3
$203K Sell
7,970
-3,925
-33% -$96.9K 0.02% 78
2025
Q2
$288K Buy
11,895
+75
+0.6% +$1.75K 0.04% 61
2025
Q1
$300K Buy
11,820
+1,914
+19% +$50.1K 0.04% 61
2024
Q4
$263K Sell
9,906
-16,001
-62% -$434K 0.03% 63
2024
Q3
$750K Buy
+25,907
New +$756K 0.1% 46
2023
Q4
Sell
-6,837
Closed -$227K 58
2023
Q3
$227K Buy
6,837
+912
+15% +$32.3K 0.04% 54
2023
Q2
$217K Buy
5,925
+245
+4% +$9.54K 0.04% 53
2023
Q1
$232K Buy
+5,680
New +$245K 0.04% 51
2022
Q3
Sell
-4,550
Closed -$239K 50
2022
Q2
$239K Sell
4,550
-3,958
-47% -$202K 0.05% 48
2022
Q1
$440K Buy
8,508
+1,750
+26% +$90.8K 0.08% 49
2021
Q4
$399K Sell
6,758
-973
-13% -$48.2K 0.07% 52
2021
Q3
$333K Sell
7,731
-2,923
-27% -$129K 0.06% 56
2021
Q2
$417K Buy
10,654
+118
+1% +$4.59K 0.07% 55
2021
Q1
$382K Sell
10,536
-1,496
-12% -$53.1K 0.07% 58
2020
Q4
$443K Sell
12,032
-121
-1% -$4.44K 0.09% 49
2020
Q3
$423K Sell
12,153
-67
-0.5% -$2.35K 0.1% 49
2020
Q2
$379K Sell
12,220
-699
-5% -$23.7K 0.1% 54
2020
Q1
$400K Buy
12,919
+1,391
+12% +$47.4K 0.12% 48
2019
Q4
$417K Buy
+11,528
New +$411K 0.11% 51

Other funds holding PFE

Absher Wealth Management's PFE Position: Q4 2025 in Review

Absher Wealth Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 7,970 shares — an estimated $203K sold.

Absher Wealth Management first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $750K in Q3 2024. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Absher Wealth Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Absher Wealth Management sold 7,970 Pfizer shares in Q4 2025, an estimated $203K.
  • Absher Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
  • Absher Wealth Management's Pfizer position peaked at $750K in Q3 2024.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Absher Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.